QureBio Ltd., a clinical-stage biopharmaceutical company focusing on development of bispecific antibodies and other engineered Biopharmaceuticals for the treatment of cancer, inflammation, and other ...
Bonus Aug 08, 2023 Aug 08, 2023 Jun 28, 2023 Bonus Ratio: 1 share(s) for every 1 shares held Bonus May 08, 2018 May 09, 2018 Mar 30, 2018 Bonus Ratio: 2 share(s) for every 5 shares held Bonus--Oct 18, ...
CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...